1. Abeloff MD, Rosen ST, Luk GD, Baylin SB, Zeltzman M, Sjoerdsma A (1986) Phase II trials of α-difluoromethylornithinean inhibitor of polyamine biosynthesis. Cancer Treat Rep 70:843–5
2. Balkwill FR (1989) Cytokines in cancer therapy. Oxford University Press, Oxford
3. Bowlin TL, McKown BJ, Sunkara PS (1986) Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines. Cell Immunol 98:341–350
4. Bowlin TL, McKown BJ, Babcock G, Sunkara PS (1987) Intracellular polyamine biosynthesis is required for interleukin-2 responsiveness during lymphocyte mitogenesis. Cell Immunol 106:420–427
5. Bowlin TL, Hoeper BJ, Rosenberger AL, Davis GF, Sunkara PS (1990) Effects of three irreversible inhibitors of ornithine decarboxylase on macrophage-mediated tumoricidal activity and antitumor activity in B16F1 tumor-bearing mice. Cancer Res 50:4510–4514